Molecular docking of selected phytocompounds with H1N1 Proteins

Area of Science:

• Virology
• Computational Chemistry
• Phytochemistry

Background:

• H1N1 influenza poses a significant global health risk.
• Current antiviral drugs (Oseltamivir, Zanamivir) have known side effects.
• These drugs inhibit viral neuraminidase and hemagglutinin, crucial for early replication.

Purpose of the Study:

• To discover novel, naturally occurring compounds for H1N1 influenza control.
• To screen phytocompounds from Tulsi (Ocimum sanctum L.) against H1N1 targets.
• To identify potential alternatives to current antiviral therapies.

Main Methods:

• Molecular docking simulations were employed.
• H1N1 viral proteins (neuraminidase and hemagglutinin) were used as targets.
• Phytocompounds isolated from the Tulsi plant were screened.

Main Results:

• Apigenin, a phytocompound from Tulsi, was identified as a potential H1N1 inhibitor.
• Apigenin demonstrated improved predicted binding properties compared to existing drugs.
• The study identified Apigenin as a promising candidate for further investigation.

Conclusions:

• Apigenin shows potential as a novel antiviral agent against H1N1 influenza.
• Natural compounds like Apigenin offer a promising avenue for developing new influenza treatments.
• Further in vitro and in vivo studies are warranted to validate Apigenin's efficacy and safety.